Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.

  title={Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.},
  author={Barbara P. Yawn and George R. Buchanan and Araba N Afenyi-Annan and Samir K Ballas and Kathryn L Hassell and Andra H. James and Lanetta B. Jordan and Sophie M. Lanzkron and Richard Lottenberg and William J. Savage and Paula Tanabe and Russell E Ware and Mohammad Hassan Murad and Jonathan C. Goldsmith and Eduardo L. Ortiz and Robinson Fulwood and Ann Horton and Joylene John-Sowah},
  volume={312 10},
IMPORTANCE Sickle cell disease (SCD) is a life-threatening genetic disorder affecting nearly 100,000 individuals in the United States and is associated with many acute and chronic complications requiring immediate medical attention. Two disease-modifying therapies, hydroxyurea and long-term blood transfusions, are available but underused. OBJECTIVE To support and expand the number of health professionals able and willing to provide care for persons with SCD. EVIDENCE REVIEW Databases of… CONTINUE READING
Highly Influential
This paper has highly influenced 18 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS
Recent Discussions
This paper has been referenced on Twitter 31 times over the past 90 days. VIEW TWEETS


Publications citing this paper.
Showing 1-10 of 196 extracted citations


Publications referenced by this paper.
Showing 1-10 of 80 references

for Disease Control and Prevention

  • US Center
  • Sickle cell disease: data and statistics. http…
  • 2014

Task Force

  • US Preventive Service
  • Recommendations. http://www…
  • 2013

Similar Papers

Loading similar papers…